Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites

Details for Australian Patent Application No. 2007216681 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Tsukada, Itaru; Sagane, Koji; Tsukahara, Kappei; Horii, Toshihiro; Nakamoto, Kazutaka; Ogawa, Kaoru; Hata, Katsura; Tanaka, Keigo

Agent Davies Collison Cave

Pub. Number AU-B-2007216681

Parent 2003282393

Filing date 7 September 2007

Wipo publication date 27 September 2007

Acceptance publication date 18 December 2008

International Classifications

C07K 14/445 (2006.01) Peptides having more than 20 amino acids

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

20 September 2007 Complete Application Filed

27 September 2007 Application Open to Public Inspection

  Published as AU-B-2007216681

18 December 2008 Application Accepted

  Published as AU-B-2007216681

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216682-Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use

2007216680-Bridge element